Mothers and midwives share their stories on a new labor pain option
NCT ID NCT07030777
First seen Apr 08, 2026 · Last updated May 23, 2026 · Updated 4 times
Summary
This study interviewed 40 women and midwives to learn about their experiences with remifentanil, a short-acting opioid for labor pain. The goal was to understand how it affects pain relief, side effects, safety, and communication during childbirth. The findings will help guide future use of remifentanil in Denmark.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MIDWIFE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Department of Anaesthesia and Intensive care, University Hospital of Southern Denmark, Kolding, Denmark
Kolding, Denmark
-
Præhospital center
Næstved, Denmark
-
University Hospital of Copenhagen, North Zealand Hospital
Hillerød, Select State, 3400, Denmark
Conditions
Explore the condition pages connected to this study.